WINTERTHUR, Switzerland (May 11, 2016)—SIGVARIS is excited to announce that it has completed a definitive agreement to purchase the BiaCare business, located in Zeeland, Michigan.
BiaCare designs and produces short stretch wraps, compression garments and other products designed to treat patients with veno-lymphatic diseases and disorders. Through this acquisition, the SIGVARIS Group will continue its international growth strategy of expanding its product offerings for patients in need of medically complex compression therapy options. The acquisition of BiaCare also allows the SIGVARIS Group to further strengthen its position in a rapidly growing market segment.
BiaCare is renowned for its high medical standards and has earned the trust of many physicians and therapists. “This transaction allows us to acquire an established manufacturer with a strong position in the U.S. market,” says Urs H. Toedtli, CEO of the SIGVARIS Group. “BiaCare’s innovative line of compression products designed to treat lymphedema, lipedema, chronic venous insufficiency and other complex edemas immediately broadens the SIGVARIS offering.”
Scot Dubé, president and CEO for SIGVARIS North America, says the acquisition will strengthen SIGVARIS’s market position as well as provide an opportunity to serve even more patients under a single brand. “By sharing our know-how, we create a platform with growth potential in North America to offer additional therapeutic medical products while strengthening our position as a solution provider for medical professionals and patients.”
Visit sigvarisusa.com for more information.
